Novo Nordisk (NVO) EV US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV | ? | 266 379 200 000 | 2 210 000 000 | -3 224 000 000 | 459 603 478 000 | 330 302 658 880 | 316 629 432 170 | ||
| Changes by years, y/y, % | +64% | -99% | -246% | -14 356% | -28% | +15.2% | |||
Novo Nordisk. EV
Novo Nordisk. EV, changes, %
Novo Nordisk (NVO) EV US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV | ? | 385 451 880 000 | 387 252 964 240 | 315 327 221 220 | 330 302 658 880 | 288 019 455 250 | 316 629 432 170 | |
| Changes by years, y/y, % | +2 087% | -48 269% | -38% | -28% | -25% | |||
| Changes by quarters, q/q, % | -16% | +0% | -19% | +5% | -13% | |||